Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 400 participants.

Also called NCT04873934

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 400 participants (enrolled count) (from the registry)
Sponsor
  • Novartis Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04873934
Other papers using this trial's data
  • Low-Density Lipoprotein Cholesterol Lowering With Inclisiran Plus Usual Care in Recent Acute Coronary Syndrome: VICTORION-INCEPTION, a Randomized, Controlled, Open-Label Trial Journal of the American Heart Association, 2026-05-19 DOI, PubMed 42132192, PMC13279551 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04873934. Randomized; no masking; primary purpose treatment. Start 2021-06-24 (actual); primary completion 2024-08-07 (actual). Results posted on 2025-08-21.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome
Acronym
V-INCEPTION
Condition
Acute Coronary Syndrome
Intervention (Drug)
Inclisiran
Lead sponsor
Novartis Pharmaceuticals (class: industry)

Record details

Record id
cardio:ct-nct04873934
Content hash
cb7d789e49ac22da442c88ee1999017a749d63879b7964d713b81ce38a5f6aa0